Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.02 | N/A | +3.55% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.02 | N/A | +3.55% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management highlighted a positive EPS surprise, indicating effective cost management. However, they did not provide specific guidance for future quarters.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They emphasized ongoing efforts to navigate market challenges.
Prestige Consumer HE's earnings report shows a solid EPS performance, which contributed to a slight increase in stock price. The positive surprise indicates that the company is managing its costs effectively, even though revenue details were not disclosed. Investors may be encouraged by the EPS beat, but the lack of guidance leaves some uncertainty about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SIMON PPTY GROUP INC REIT
Nov 1, 2021